Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier
Journal of Clinical Investigation · 15.06.2026 · 136 (12)
DOI: 10.1172/jci207335 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.06.2026. Verfasst von Davide Ruggero. Beteiligte Einrichtung: Helen Diller Family Comprehensive Cancer Center. Hauptthemen laut MEDLINE: Protein Biosynthesis, Proteome, Prostatic Neoplasms, Neoplasm Proteins. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer proteogenomics has revealed that RNA abundance often poorly predicts protein output, highlighting translation as a central determinant of malignant identity. In this issue of JCI, Mishra et al. showed that pharmacologic inhibition of eIF4E cap binding selectively rewired the prostate cancer translatome, suppressing basal keratin translation while promoting luminal features and renewed sensitivity to hormone therapy. More broadly, the study illustrates how tumors exploit selective translation to maintain lineage plasticity, survival, and therapeutic resistance. Targeting translational dependencies may therefore offer a powerful strategy to dismantle cancer-specific proteomic programs and convert resistant cell states into druggable vulnerabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Helen Diller Family Comprehensive Cancer Center.
- School of Medicine and Department of Urology, and.
- Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, California, USA.
Zitieren
APA
Ruggero, D. (2026). Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier. Journal of Clinical Investigation, 136(12). https://doi.org/10.1172/jci207335
Vancouver
Ruggero D. Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier. Journal of Clinical Investigation. 2026;136(12). doi:10.1172/jci207335
BibTeX
@article{Ruggero2026,
author = {Ruggero, Davide},
title = {Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {12},
doi = {10.1172/jci207335}
}
EUVIMED